Home > Financial Ratios > ALEMBIC PHARMACEUTICALS

ALEMBIC PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
ALEMBIC PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

ALEMBIC PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.2735.24-23.09-41.0227.66

What is the latest Core EBITDA Growth ratio of ALEMBIC PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of ALEMBIC PHARMACEUTICALS is 9.27 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.27
Mar202435.24
Mar2023-23.09
Mar2022-41.02
Mar202127.66

How is Core EBITDA Growth of ALEMBIC PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 9.27
-73.69
Mar2024 35.24
Positive
Mar2023 -23.09
Negative
Mar2022 -41.02
Negative
Mar2021 27.66 -

Other Financial Ratios of ALEMBIC PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of ALEMBIC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS ₹13,243.0 Cr -5.4% -14.6% -17.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,693.0 Cr -1.7% 4% 11.8% Stock Analytics
DIVIS LABORATORIES ₹161,270.0 Cr -4.7% -1.8% 10.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,281.0 Cr -3.7% 4.5% 42.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,422.0 Cr -3% 0% 15.4% Stock Analytics
CIPLA ₹104,915.0 Cr -2.6% -2.3% -10.1% Stock Analytics


ALEMBIC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALEMBIC PHARMACEUTICALS

-5.4%

-14.6%

-17.7%

SENSEX

-2.7%

-10.4%

1.6%


You may also like the below Video Courses